WAFB Channel 9, Baton Rouge, LA |Pfizer's Geodon gets expanded FDA approval
Member Center:
 |
 |
NEW YORK (AP) - Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.
The new approval covers use of Geodon as an adjunct to lithium or valproate.
The drug is already approved as a treatment for schizophrenia and bipolar disorder.
Shares of Pfizer rose 20 cents to $18.31 in afternoon trading.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
